Compare Recursion Pharmaceuticals Inc (RXRX) vs Tractor Supply Co (TSCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Recursion Pharmaceuticals Inc vs Tractor Supply Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while Tractor Supply Co trades at $29.65 (market cap $15.89B). The key difference: Tractor Supply Co is far larger — about 10.4× Recursion Pharmaceuticals Inc's market cap, and Tractor Supply Co pays a 3.17% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | TSCO | |
|---|---|---|
Market Cap | $1.53B | $15.89B |
Sector | Health | Consumer Cyclical |
52-Week High | $6.79 | $62.65 |
52-Week Low | $2.84 | $29.14 |
Enterprise Value | $946.50M | $22.08B |
Dividend Yield | — | 3.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Recursion Pharmaceuticals (RXRX) trades at $2.89, down 1.87% with a bearish technical signal despite recent earnings beats. The company shows significant revenue growth challenges with 2025 revenue of $74.26M but massive losses of -$644.76M, resulting in a -851.51% net margin. Analyst sentiment is mixed with 40% buy ratings but a consensus price target of $7.83, representing 171% upside potential from current levels.
While RXRX offers substantial upside based on analyst targets, the stock carries high risk due to persistent losses, negative cash flow from operations, and unproven AI-driven drug discovery platform. The company's heavy reliance on financing activities to fund operations presents ongoing dilution risk, making this suitable only for risk-tolerant investors betting on long-term biotech breakthroughs.
Tractor Supply (TSCO) trades at $29.64, down 2.85% today, with a bearish technical outlook but solid fundamentals including 36.4% gross margins and 45.5% ROE. Recent earnings show mixed results with two misses but a strong Q2 expectation of $0.83 EPS. The company maintains stable revenue growth, reaching $15.5B in 2025, and announced a $0.24 dividend for H1-26.
Despite near-term headwinds, TSCO's strong market position and analyst consensus price target of $38.40 suggest 30% upside potential. Risks include consumer discretionary pressure and recent earnings volatility, but the stock's current valuation at 14.9x P/E presents a compelling entry point for long-term investors seeking exposure to the resilient rural lifestyle retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →About Tractor Supply Co
Tractor Supply is the largest operator of retail farm and ranch stores in the United States. The company targets recreational farmers and ranchers and has little exposure to commercial and industrial farm operations. Currently, the company operates 2,016 of its namesake banners in 49 states and 178 Petsense stores. Stores are typically located in towns outside of urban areas and in rural communities. In fiscal 2021, revenue consisted primarily of livestock and pet (47%), hardware, tools, and truck (21%), and seasonal gift and toy (21%).
Read more on TSCO →
